Journal article
T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION
Monika Schlögelhofer, Patrick D McGorry, Barnaby Nelson, Connie Markulev, Hok Pan Yuen, Miriam Schäfer, Nilufar Mossaheb, Stefan Smesny, Ian B Hickie, Gregor Berger, Eric YH Chen, Lieuwe de Haan, Dorien H Nieman, Merete Nordentoft, Anita Riecher-Rössler, Swapna Verma, Andrew Thompson, Alison Ruth Yung, G Paul Amminger
Schizophrenia Bulletin | Oxford University Press (OUP) | Published : 2018
Open access
Abstract
Adherence to a medication is generally defined as the extent to which patients take medications as prescribed by their health care providers. Poor adherence to study medication is not uncommon posing a major challenge to treatment trails. However, poor adherence may not be randomly distributed but rather be associated with demographic or illness factors. The aim of the present study was to identify factors associated with adherence to study medication in young people at ultrahigh risk of psychosis who participated in the NEURAPRO study. Secondary analysis of data collected in a multi-centre, double-blind, placebo-controlled, randomized clinical trial to prevent or delay the onset of psychosi..
View full abstract